Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation

Puntos clave

• Examine malpractice claims related to pancreatic cancer, focusing on claim rates and outcomes.
• Analyzed claim data over a specified period
• Identified causes of claims
• Assessed approval rates and compensation amounts
• Claim rate remained stable at 1.5%
• One in five claims were approved
• Diagnostic delay was the primary reason for claims

Resumen